BackImmunogen Overview

Immunogen Profit Margin

Profitability ratio analysis for IMGN.

Quarterly Profit Margin

27.11%
105.36% YoY

As of Sep 2023

Annual Profit Margin (TTM)

-25.41%
87.92% YoY

Trailing 12 months ending Sep 2023

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading